ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:1900454;positive regulation of long term synaptic depression;9.0;1.0;0.896240625180289;9.628524252492122;54.16329535062315;8.16763571524637;0.0018127967515842568;0.8139338954918922;[LILRB2]
GO:0045963;negative regulation of dopamine metabolic process;8.0;0.9326813400603323;0.8413406700301662;9.574457031221845;288.50442548003474;8.390779266560578;0.0096559834836909;0.8041048419030481;[ITGAM, ITGB2]
GO:0043542;endothelial cell migration;7.0;0.7980440201809971;0.7499413753476991;9.143016436710422;24.971868181253015;5.71663061713405;8.357859548042604E-4;0.6432681208679463;[NRP1, PLXND1, ITGB2, CXCL13, LOXL2, DPP4, CYP1B1, EGR3, TNFSF12, PTK2, NR4A1, ID1, S100P]
GO:0051092;positive regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.4401483168805;4.8283137373023015;0.009352610284359957;0.6950405016553352;[TNF, CLU, PYCARD, TNFSF11, BTK, PRKCQ, S100A8, CARD11, TNFRSF11A, NLRP3, S100A12, TGFB1, NFKB1, MYD88, CD40, ITGB2, CD36, CHUK, IRAK3, TRAF1, PSMA6, IL1B, TLR6, TLR4, LTF, TLR2, NLRC4, NOD2, CD40LG]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[NRP1, ECM1, CD40, SERPINE1, ITGB2, BRCA1, AQP1, CDH5, C3AR1, CTSH, CYP1B1, ITGB8, CD34, GHSR, ANXA1, ANXA3, GAB1, SIRT1, F3, SFRP2, IL1B, ADAM12, AGTR1, CHI3L1, ENG, CX3CR1, C5AR1, TWIST1, PTGS2, DLL1, THBS1, CXCR2, HMOX1, PLCG1, JUP, PLK2, TNFSF12, KLF4, LRG1, TEK]
GO:0060326;cell chemotaxis;5.0;0.6393367784920305;0.6099094011069355;8.152617732682543;30.286927728949156;4.458953633836253;0.0010136762146226118;0.5182721080578558;[IL1RN, CSF3R, CXCL13, CXCL16, LGALS3, EDNRB, CCRL2, C3AR1, TNFSF11, IL6R, EPHB1, PDGFRB, PDGFRA, CXADR, PRKCD, CH25H, HOXB9, BIN2, AGTR1, PRKCQ, S100A8, EPHA2, CALCA, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, CORO1A, NUP85, S100A12, NCKAP1L, CCR10, CCR1, TGFB2, EGR3, VCAM1, AZU1, DEFA1, PPBP, NR4A1, CXCL10, CXCL11, IL6, CXCL12, NRP1, CXCL6, CXCL9, ITGB2, HMGB2, CXCL1, CXCL3, CXCL2, CXCL5, CCR9, PDE4B, FFAR2, CCR7, CCR6, CCR5, CCR2, ANXA1, FCER1G, SYK, RHOG, GAB1, VAV1, IL1B, KIT, XCL1, HBEGF, CX3CR1, CCL13, CXCR5, CXCR4, CXCR6, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL21, CCL20, PF4]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[MPL, PHB2, SLC8A1, LOXL2, AQP1, PLAU, MYB, AKT1, ACTN4, ATP1B1, CLDN3, ABCB4, PSEN2, TWIST1, DPP4, HMOX1, EGR1, TGFB2, TGFB1, VCAM1, CAV1, NR4A2, BMP2, CXCL12, NOX4, CD24, SUV39H1, ALAD, MYOCD, ADSL, KCND2, MMP2, AGTRAP, SIRT1, CBFA2T3, TGFBR3, CCNA2, IL1B, LTA, TLR2, CXCR4, KCNA5, PTGS2, THBS1, PAK1, E2F1, TEK]
GO:0009308;amine metabolic process;4.0;0.5295311121456219;0.5147655560728109;6.961296045910167;23.636994252021474;5.649939242635378;7.911089257014214E-4;0.5389381556174175;[SLC44A1, ACMSD, VCAM1, KMO]
GO:0051926;negative regulation of calcium ion transport;8.0;0.7140352122741334;0.7320176061370667;8.890925309361343;69.46225493434336;5.666199763507158;0.0023248391606816524;0.6647697194109919;[FMR1, PTGS2, PLN, DRD4, TGFB1, LILRB1, LILRB2, GEM]
GO:2000353;positive regulation of endothelial cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;129.82178199018807;6.943860283624253;0.00434501821119318;0.7513499630073597;[CD40, ITGA4, FASLG, THBS1, CD40LG, CCL2, PLCG1]
GO:0032689;negative regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.343086423195323;0.002184000309729388;0.647506047256038;[CD274, CD96, LILRB1, INHBA, PDCD1LG2, GATA3, XCL1, TLR4, HAVCR2]
GO:0051248;negative regulation of protein metabolic process;6.0;0.4463712279514003;0.5463059265658446;6.752138736570697;129.5306506172274;2.7979283526116596;0.004335274306141412;0.46620649865967934;[PID1, SPI1, SERPINE1, SPINT2, AKT1, DAPK1, PRKCD, SPINT1, PRKAR1B, ATF3, FLRT2, PRKAR2B, SFN, NCKAP1L, ELANE, LYN, JUN, PLK1, PKIG, CDKN1A, SERPINA1, LRRC4, TIMP2, TIMP3, TIMP1, DUSP2, DUSP1, SERPINB9, PAX5, SIRT1, DUSP6, PAX2, GAS1, HBEGF, ENG, SERPINB10, LRRC19, PTGS2, NTF3, FLNA, DMD, CDKN2C, NR1H2, PKN1, FMR1, PROS1, TNF, CLU, PYCARD, MEN1, LAG3, FOXO1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, PTPRC, CNOT3, LRRK2, ITGB3, PTPN22, ALAD, HHEX, DUSP10, EMILIN1, CR1, TNFRSF1B, BIRC5, PPP1R15A, NLRC4, FYN, CSK, KLF4, EIF3E, PTPN6, AQP1, EDNRB, PPP2R1A, RPS6KA1, FBXO5, SOX4, IL1R2, PAQR3, MIF, POR, SFRP2, SLPI, NAIP, TWIST1, INPP5D, TNFSF14, LIF, ITM2A, ITM2C, PTPRR, ECM1, CTSZ, BRCA1, GP1BA, CEACAM1, BANK1, IL1B, TLR4, IFI6, GNAI2, TM4SF20, LILRB1, LILRB2, PODN, NLRP12, MAD2L1, GHSR, TSC2, FBLN1, TGFB1, CAV1, CRIM1, INHBA, EIF2S1, IL6, LIN28A, TNFAIP3, LRRTM4, NUP62, MYOCD, IRAK3, MMP9, DCN, COL6A3, LTF, TAF9, THBS1, SPOCK3, PTX3]
GO:0030183;B cell differentiation;6.0;0.7307253602413294;0.6884829927108091;9.022388448921806;64.35544597283358;5.2552850506314295;0.0021539188605695985;0.5918758344751833;[IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, HHEX, BLNK, TPD52, CR2, IFNA14, ITGA4, IFNA16, NFAM1, ATP11C, MSH2, KIT, CARD11, IFNA10, DLL1, CD79B, CD79A, NKX2-3, IFNA21, VCAM1, CD40LG, BCL6, FCGR2B, ITM2A]
GO:1905875;negative regulation of postsynaptic density organization;8.0;1.0;0.875;9.628524252492122;179.1445802505115;9.777073627680469;0.005995807881329661;0.875;[LILRB2]
GO:0002291;T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell;7.0;1.0;0.8509193652572005;9.628524252492122;83.84221930200768;8.67846133901236;0.002806123626939655;0.7947362817240173;[ITGAL]
GO:0034142;toll-like receptor 4 signaling pathway;12.0;0.8436909121759173;0.8699657686781033;9.485423408851448;412.6549923027037;6.943860283624253;0.013811191226989502;0.8032296504172152;[ITGAM, ITGB2, LY96, NFKBIA, S100A14, TLR4]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[CDA, CYFIP1, ABCA13, C3AR1, PRKCD, RNASE3, RNASE2, BIN2, PADI2, FPR1, FPR2, GNS, S100A12, NCKAP1L, ELANE, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, PTAFR, ALOX5, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, SLC27A2, S100A8, BRI3, HVCN1, GPR84, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, HPSE, ITGAM, ITGB2, ITGAL, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, TTR, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CTSB, CCT2, FCER1G, MME, RHOG, CEACAM1, CEACAM6, TLR2, LILRA3, CXCR1, CXCR2, CD58, CCT8, LILRB2, LILRB3, QPCT, CD68, PLAU, CD97, CHRNB4, CD93, OSCAR, DOK3, PRTN3, VCL, PSMD14, C5AR1, MGAM, SELL, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, MMP8, MMP9, FGR, CHI3L1, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0042102;positive regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;564.8543510249671;5.212725436212633;0.018905166792893686;0.6628196464047262;[CD86, TFRC, CD80, CD3E, TNFSF13B, PYCARD, IL6R, ICOSLG, CCR2, HLA-DPA1, HAVCR2, ANXA1, SYK, PDCD1LG2, ZAP70, IL1B, XCL1, PRKCQ, CARD11, CD274, BLM, HHLA2, CD1D, CORO1A, HLA-DMB, CCL5, NCKAP1L, CCL19, IL12RB1, VCAM1, LILRB2, CD4, IL6, CD40LG, PTPRC, CD6, DNAJA3, CD28, HLA-DPB1, CD24]
GO:0043113;receptor clustering;6.0;0.7671156992804218;0.7066781622303554;8.992535485772125;42.889232177334534;5.9928839937622085;0.0014354640031724087;0.6295966787287501;[NLGN1, ITGA4, ITGB2, ITGAL, DNAJA3, FLNA, ITGB7, SHANK3]
GO:0043315;positive regulation of neutrophil degranulation;11.0;1.0;0.9324289523296623;9.628524252492122;798.7725987099202;8.390779266560578;0.0267342000301538;0.8615337942327104;[ITGAM, PTAFR, ITGB2, CD177]
GO:1990771;clathrin-dependent extracellular exosome endocytosis;8.0;1.0;0.875;9.628524252492122;77.4609371141217;9.777073627680469;0.002592547854892228;0.875;[ITGA4]
GO:2000406;positive regulation of T cell migration;10.0;0.7980440201809971;0.8142630219514189;9.461470167828956;351.7821234142529;6.518977089658987;0.011773831087318304;0.7486218033895181;[TNFSF14, CCL21, ITGA4, CCL20, CXCL13, PYCARD, CXCL10, CXCL12, CCL5, XCL1, CCR2]
GO:0002523;leukocyte migration involved in inflammatory response;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;29.137022145890857;7.379178354882098;9.751899096054872E-4;0.7004918368257019;[ITGB2, FFAR2, CCR6, SELE, ELANE, S100A8, JAM3]
GO:0035987;endodermal cell differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;6.444869117505266;7.050676185779127E-4;0.5795909063862833;[LAMB3, ITGB5, ITGA4, COL11A1, MMP2, LAMA3, COL12A1, ITGB2, FN1, LAMB1, INHBA, MMP8, MMP9, COL8A1, ITGA7]
GO:0002728;negative regulation of natural killer cell cytokine production;9.0;1.0;0.896240625180289;9.628524252492122;694.1135629292197;9.777073627680469;0.023231356289590815;0.896240625180289;[CD96]
GO:0035307;positive regulation of protein dephosphorylation;9.0;0.811012628672052;0.801746939516315;9.464221201200845;660.9024749708963;6.063501560976162;0.022119811063664396;0.706328376990269;[PPP1R15A, PDGFRB, TGFB1, PPP1R12A, FCRL3, PRKCD, LILRB2]
GO:2000363;positive regulation of prostaglandin-E synthase activity;6.0;1.0;0.8231203125901445;9.628524252492122;43.017486512842105;8.67846133901236;0.001439756560360439;0.7669372290569613;[ITGAM, ITGB2, NOD2]
GO:0032755;positive regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.94897299966192;5.395046993006588;0.0021737836760178982;0.5990232667078439;[IL1RN, TNF, PYCARD, CD36, IL6R, FCER1G, F2R, EREG, TLR1, ADCYAP1, IL1B, TLR8, TLR7, TLR6, TLR4, TLR2, PTAFR, TWIST1, NOD2, HSPD1, CARD9, LILRB2, IL6, MYD88, IL17A]
GO:0031623;receptor internalization;7.0;0.7248374789738407;0.7133381047441208;9.201080237665183;64.84818556283533;5.682729065458369;0.0021704104112101165;0.6415343939386686;[CALCRL, LRP1, TFRC, ITGB2, CXCR1, CXCR2, CD36, AP2M1, FCER1G, SYK, CAV1, LILRB1, DNM2, CEACAM1, CD9, RAMP1]
GO:0071404;cellular response to low-density lipoprotein particle stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;56.74958382123113;7.004484905440688;0.0018993574991869968;0.6813299963962409;[ABCA1, FCER1G, SYK, ITGB2, CD9, CD36]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[CYFIP1, PLXND1, EPS8, TPM1, VRK1, CSF1R, ARHGAP15, CORO1A, SPTA1, MYH14, FN1, PTK2, PLXNB2, ITGB2, ANXA1, RHOG, ARAP3, RHOH, ARAP1, FGR, HCK, KIT, ITGA7, RHOU, CCL13, FGD3, FGD4, CCL7, PDPN, CCL2, FYN, WASF3]
GO:0046718;viral entry into host cell;7.0;0.7671156992804218;0.7344772148974115;8.935377071932177;28.374411874040543;5.346256828837156;9.496660301113433E-4;0.6243271881103005;[SCARB2, CD86, TFRC, ITGB5, CD80, ITGB3, F11R, ANPEP, CLEC5A, ITGB7, ITGB6, HAVCR1, CTSB, CR2, CR1, CXADR, EPHA2, GYPA, DPP4, NCAM1, GPR15]
GO:0035584;calcium-mediated signaling using intracellular calcium source;8.0;1.0;0.875;9.628524252492122;30.117246255164275;6.781341354126479;0.0010079971283984438;0.7217981122146513;[GRM5, VCAM1, CCL20, AZU1]
GO:0045429;positive regulation of nitric oxide biosynthetic process;8.0;1.0;0.875;9.628524252492122;658.6394256443023;6.166155715036245;0.02204406883931546;0.6903374900225189;[ITGB2, PTGS2, TNF, CLU, KLRK1, AKT1, CD36, AGXT2, KLF4, DNM2, IFNG, IL1B, PTX3, TLR6, TLR4]
GO:0090314;positive regulation of protein targeting to membrane;10.0;0.9326813400603323;0.8815816818910864;9.587702257971866;497.0805077511855;6.343086423195323;0.016636837251019197;0.7396267465268138;[, ITGAM, ITGB2, PAK1, FYN]
GO:1900271;regulation of long-term synaptic potentiation;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;41.65758488823441;6.193554689224359;0.0013942418768168238;0.6917386748366816;[CX3CR1, LILRB2, NRGN, SHANK3]
GO:2001198;regulation of dendritic cell differentiation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;68.77525917473399;7.474488534686424;0.0023018460308635697;0.7331650565203278;[TMEM176B, TMEM176A, LILRB1, LILRB2, FCGR2B]
GO:1903980;positive regulation of microglial cell activation;8.0;1.0;0.875;9.628524252492122;155.50143499853152;7.697632086000634;0.005204493087195169;0.7686572628545723;[ITGAM, LRRK2, ITGB2, STAP1]
GO:1905564;positive regulation of vascular endothelial cell proliferation;8.0;1.0;0.875;9.628524252492122;108.29290547333461;7.138016298065211;0.0036244660889050463;0.7400384854347593;[GHSR, ITGA4, PLCG1]
GO:0090074;negative regulation of protein homodimerization activity;6.0;1.0;0.8231203125901445;9.628524252492122;47.53015703769362;8.16763571524637;0.0015907915816874183;0.7408135829017477;[ITGA4, ID1]
GO:0002223;stimulatory C-type lectin receptor signaling pathway;11.0;1.0;0.9324289523296623;9.628524252492122;628.1099736002739;5.618190544320798;0.02102227555412486;0.7197434780388068;[CLEC10A, ICAM2, ICAM3, PAK1, KLRK1, FYN, MUC15, PRKACB, LYN, FCER1G, CHUK, SYK, CARD9, PRKCD, NFKB1, CLEC4D, CARD11]
GO:0002774;Fc receptor mediated inhibitory signaling pathway;8.0;1.0;0.875;9.628524252492122;130.16139686502353;8.67846133901236;0.004356384815420379;0.8188169164668168;[LYN, LILRB1, LILRB2]
GO:0045591;positive regulation of regulatory T cell differentiation;10.0;0.8933024483968273;0.861892236059334;9.60254876608886;997.8066164740876;7.292166977892469;0.03339568948573388;0.7881627702307852;[TGFB1, DUSP10, BCL6, IFNG, LILRB2]
GO:0045471;response to ethanol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;69.73224034292265;5.006389003214805;0.0023338753293357085;0.5462679783062231;[SPI1, SPARC, TNC, EEF1B2, ALAD, ADCYAP1, CLDN3, IL1B, CLDN7, S100A8, PSMD14, GATA3, CCL7, CNR1, FYN, GSN, VCAM1]
GO:0050730;regulation of peptidyl-tyrosine phosphorylation;9.0;0.6873818243518346;0.7399315373562063;9.0689084645567;111.97076766282173;4.31748811353631;0.003747560826526104;0.6170371680902661;[CD80, PPP2R1A, IL6R, PRKCD, MIF, EREG, SFRP2, CSF1R, TGFA, PDGFD, PDGFC, STAP1, LYN, TGFB1, ACE, CAV1, LIF, BST1, GH1, IL6, CSPG4, CD24, NRP1, CD40, ITGB3, IFNA2, ITGB2, TREM2, CD3E, GHR, GRM5, CD36, SYK, IFNG, BANK1, KIT, HBEGF, CCL5, NTF3, FYN, EGF, CD4, PTPN6]
GO:0002534;cytokine production involved in inflammatory response;3.0;0.9326813400603323;0.6644609826203107;9.405380701177911;21.07076093796092;8.67846133901236;7.052194061398546E-4;0.6419372290569613;[CD96, SEH1L]
GO:0007229;integrin-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;5.311165509025885;8.87013979980389E-4;0.5947335637161829;[NRP1, ITGAM, ITGB5, ITGB4, ITGB3, ITGA2B, ITGB2, ITGAL, CTGF, ADAMTS1, ITGAX, ITGB8, ITGB7, ITGB6, FCER1G, SYK, ITGA4, VAV1, FGR, HCK, CEACAM1, ADAM9, ITGA7, TLN1, PTK2, ZYX, PLP1, LAT]
GO:0002578;negative regulation of antigen processing and presentation;5.0;0.6913464685778243;0.6359142461498324;8.48339194818912;38.82783361315856;7.8311634786251565;0.0012995326482508427;0.6907270763441554;[LILRB2, FCGR2B, HLA-DOA, HLA-DOB, THBS1]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[AKT1, PRKCD, FPR1, GATA3, FLRT2, HMOX1, HLA-DQA2, HLA-DQA1, HLA-DRB4, FN1, COL1A2, HLA-DRB1, CDKN1A, LRRC4, TIMP1, HLA-DPA1, ANXA1, IFNGR1, FOS, SIRT1, F3, FCER2, HLA-DQB1, CCL13, LRRC19, PTAFR, PTGS2, ALOX5, STAT4, CCL19, CCL18, IL12RB1, IL12RB2, CCL23, CCL21, CCL20, HLA-DPB1, PF4, CSF3R, F13A1, IL5RA, CXCL13, TNF, PYCARD, IGHG1, IL13RA2, IL13RA1, IFNA14, IFNA16, IFNA10, CSF1R, TNFRSF11A, FOXO1, TNFRSF17, IFNA21, TNFRSF10C, TNFRSF10B, NFKB1, CXCL10, CXCL11, CXCL12, BCL6, LCN2, HLA-DRA, MYD88, CIITA, ITGAM, ITGB2, FASLG, TNFSF13B, ITGAX, CHUK, TNFRSF1B, IL3RA, XCL1, BIRC5, CX3CR1, NOD2, IL2RG, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, FCGR1B, IL2RB, PTPN6, IL1RN, TNFSF11, ACSL1, IL1R1, IL1R2, FLT3LG, MIF, EREG, IFI27, TWIST1, INPP5D, CCR10, CCR1, EGR1, TNFSF14, TNFSF12, TNFSF13, LIF, PPBP, SDC1, IFNA5, IFNA4, IFNA7, CD40, TNFRSF13B, IFNA2, IFNA8, CCR9, CCR7, CCR6, CD36, CCR5, CCR2, SYK, GP1BA, IL17RB, VAV1, HCK, CEACAM1, IL1B, KIT, RHOU, CXCR5, IFI6, CXCR4, CXCR6, CXCR1, CXCR2, PODN, CD40LG, IL18R1, IL17A, CD86, CD80, MPL, IL18RAP, CCRL2, IL6R, PRTN3, CSF2RB, TGFB1, VCAM1, NFKBIA, IL6, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, GHR, LRRTM4, MMP1, MMP2, IRAK3, MMP9, DCN, IFNG, LTA, SAMHD1, NCAM1, CD4, LTBR]
GO:0034446;substrate adhesion-dependent cell spreading;6.0;1.0;0.8231203125901445;9.628524252492122;56.23121614310476;6.088194173566533;0.0018820081995007299;0.63447084575632;[NRP1, ITGA4, ITGB3, FN1, LAMB1, LAMC1, ANTXR1, ITGB7, TEK]
GO:0071356;cellular response to tumor necrosis factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;4.973052582947213;0.0027327542132076126;0.5774424529526606;[PID1, BRCA1, PYCARD, TCL1A, AKT1, CHUK, SIRT1, CHI3L1, XCL1, CCL13, CALCA, GATA3, ADAMTS12, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, CCL23, VCAM1, CCL21, CCL20, MAPK14, NFKB1, COL1A1]
GO:0050776;regulation of immune response;4.0;0.37937792944451876;0.4396889647222594;5.635843344046521;22.446924158408432;2.846578861728843;7.512783506617425E-4;0.39557417536826767;[, CYFIP1, TFRC, CLEC10A, SLA2, MYB, TRBC1, C3AR1, UBASH3A, PRKACB, MEF2C, CXADR, PRKCD, PRKCQ, HHLA2, FPR1, FPR3, FPR2, GATA3, KLRK1, HMOX1, NCKAP1L, S100A14, PLCG1, IGHA1, HLA-DQA2, HLA-DQA1, ELANE, LYN, JUN, HLA-DRB4, FZD5, KIR2DS1, KIR2DS2, COL1A1, COL1A2, HLA-DRB1, DENND1B, ITK, SIGLEC9, CTLA4, HLA-DPA1, HAVCR2, ANXA1, ARG1, IFNGR1, FCRL3, NFAM1, PAWR, SERPINB9, PAX5, FOS, SIRT1, MMP12, FCER2, TLR10, HLA-DQB1, PTAFR, UNG, HLA-DMB, CCL19, IL12RB1, NR1H2, CARD9, KIR3DL1, HLA-DPB1, PKN1, CLC, LGR4, PROS1, CXCL13, TNF, CLU, PYCARD, IGHG1, FCGRT, GRAP2, IL13RA2, CD177, LAG3, CD180, MSH6, ADCYAP1, CLEC4D, MSH2, S100A8, BLK, CD274, LY96, CLEC7A, IGLV1-44, MAP2K6, EIF2B3, BMX, NFKB1, PTPRC, BCL6, HLA-DRA, LAT, MYD88, ITGAM, ITGB2, TREM2, PTPN22, ITGAL, TREM1, TNFSF13B, FCGR3A, DUSP10, ITGB7, CR2, CR1, CHUK, ITGA4, PVRIG, LCK, XCL1, LCP2, UNC93B1, NLRC4, NOD2, CCL5, FYN, CSK, FCGR1B, FCGR2A, PTPN6, MNDA, CD247, FCGR2B, CLEC2D, ICAM2, ICAM3, LGALS3, ICOSLG, SLC11A1, MIF, EREG, BTK, STXBP2, CD1E, CD1D, CD1C, CD1B, CD1A, CD79B, CD79A, CD19, INPP5D, SLAMF7, PAG1, SH2D1A, TNFSF13, PTK2, MARCO, CD28, CD24, CD200, IGHM, ECM1, CD40, IFNA2, CD3G, CD3E, CD3D, CTSS, RAC2, FCER1A, CTSH, FFAR2, CTSG, CCR7, MUC15, CD36, CD34, CD33, CCR2, FCER1G, SYK, LIME1, VAV1, LAT2, TLR1, NCR1, HCK, CEACAM1, IL1B, KIT, IGHD, TLR8, TLR7, TLR6, TLR5, TLR4, TLR2, C1QA, PAK1, IGKC, NPDC1, LILRB1, LILRB2, MLH1, CD40LG, CD86, CD80, TRAC, IL18RAP, IL6R, CD96, THEMIS, OSCAR, KLRF1, CD300C, CARD11, KLRB1, C5AR1, KIR2DL1, KIR2DL2, CACNA1F, KIR2DL3, KIR2DL4, STAP1, NLRP3, TGFB2, TGFB1, VCAM1, CAV1, NFKBIA, IL6, NR4A3, SELL, KLRD1, IGKV3-20, HMGB2, TNFAIP3, PDE4B, MMP2, IRAK3, FGR, ZAP70, IFNG, LTA, LTF, COLEC12, CLEC12B, SAMHD1, HSPD1, CNR1, TRAT1, MAPK14, CD4]
GO:0060333;interferon-gamma-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.514393750639154;0.00101047745553359;0.6329257181104212;[CIITA, HLA-DPA1, IFNGR1, PRKCD, HCK, IFNG, HLA-DQB1, PTAFR, NCAM1, FCGR1B, HLA-DQA2, HLA-DQA1, HLA-DRB4, VCAM1, HLA-DPB1, HLA-DRA, HLA-DRB1]
GO:0033198;response to ATP;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;115.93137747960115;6.375876246018314;0.0038801188727762915;0.6491829203200885;[TRPC3, PTGS2, SLC8A1, P2RX5, SELL, P2RX1, IL1B]
GO:0050904;diapedesis;6.0;0.8933024483968273;0.7697715367885581;9.510741216835738;29.137022145890857;8.390779266560578;9.751899096054872E-4;0.7522251544931926;[ITGA4, PECAM1]
GO:1903238;positive regulation of leukocyte tethering or rolling;10.0;1.0;0.9152410118609203;9.628524252492122;440.9461040801303;8.390779266560578;0.014758069277832396;0.8443458537639685;[ITGA4, PTAFR, ELANE, CCR2]
GO:0035094;response to nicotine;4.0;0.9326813400603323;0.7163406700301662;9.446202695698167;26.17342148764107;5.926926025970411;8.760008626412986E-4;0.5531032725983739;[CHRNB4, VCAM1, SLC7A11, TNF, NFKB1, CNR1, HMOX1]
GO:1901216;positive regulation of neuron death;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;58.38287487682085;5.370354380416217;0.001954022280951067;0.5977604853516485;[ITGAM, CTSZ, ITGB2, FASLG, CLU, MYB, FOS, KMO, IL1B, TLR6, TLR4, TP53BP2, FYN, EGR1, JUN, TGFB2, EIF2S1, FCGR2B, UBE2M]
GO:0001774;microglial cell activation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;31.19674186509269;6.8867018697843045;0.001044126874979773;0.6753065664753021;[CX3CR1, JUN, ITGAM, ITGB2, TLR8, TLR7, FPR2, AZU1, TLR6, CLU, TLR2]
GO:0002666;positive regulation of T cell tolerance induction;7.0;0.8653626801206646;0.7836007053175329;9.4949928598676;165.82106058012107;7.8311634786251565;0.005549881668350914;0.7514054297404357;[LILRB2, CD3E]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[CD86, CXCL6, CXCL9, CD40, IL1RN, CD80, SERPINE1, HMGB2, TNFAIP3, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, PYCARD, EDNRB, PDE4B, CTSG, CD36, CCR5, HAVCR2, GHSR, MEF2C, ARG1, CD180, PDCD1LG2, TNFRSF1B, IL1B, ADAM9, TLR4, CX3CR1, CD274, CEBPE, KLRK1, STAP1, NLRP3, CCL2, ABCA1, CCL20, NR1H2, DEFA4, LILRB1, DEFA1, LILRB2, PPBP, MAPK14, NFKB1, CXCL10, CXCL11, IL6, PF4]
GO:0045123;cellular extravasation;6.0;0.7671156992804218;0.7066781622303554;8.999915593069748;29.137022145890857;7.379178354882098;9.751899096054872E-4;0.7004918368257019;[ITGB2, PECAM1, CCL2, PRTN3, AZU1, CD177]
GO:0042130;negative regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;581.9323154417883;5.734022359845919;0.01947675089275457;0.6894787953221185;[CD86, CD274, CD80, LRRC32, GPNMB, CTLA4, HAVCR2, TGFB1, ARG1, PAWR, LILRB1, PDCD1LG2, LILRB2, XCL1, PTPN6, PDE5A]
GO:0006909;phagocytosis;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;28.437470009997963;5.618190544320798;9.517765291732001E-4;0.610434838299289;[ITGB3, NCF4, ICAM3, ITGAL, CD36, ANXA1, CD93, ANXA3, SLC11A1, DNM2, PECAM1, PRTN3, CD302, LRP1, CEBPE, PLD4, CORO1A, ELANE, MARCO]
GO:0030593;neutrophil chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;130.2972973825895;5.382624473008031;0.004360933283440787;0.671508291047556;[CXCL6, CCL13, CXCL9, IL1RN, CSF3R, C5AR1, ITGB2, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, LGALS3, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCL4, PDE4B, CCL2, S100A12, CCL1, NCKAP1L, CCL19, CCL18, CCL23, TGFB2, CXADR, FCER1G, SYK, CCL21, CCL20, PPBP, VAV1, CXCL10, CXCL11, IL1B, XCL1, S100A8, PF4]
GO:0072678;T cell migration;7.0;0.7140352122741334;0.7079369713942671;8.8813098506619;30.235634434558513;6.686031174322154;0.001011959474220325;0.692843310444282;[CXCL9, GPR15, CCL20, DEFA1, CXCL16, CXCL10, ZAP70, CXCL11, CCL2, ITGB7, CCR6, CCR2]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[CD86, IL1RN, SPARC, CD80, SERPINE1, CXCL13, PYCARD, EDNRB, GHSR, CD96, MEF2C, SLC11A1, CD180, F2R, KMO, SLPI, ADAM9, S100A8, CD274, ABCB4, C5AR1, MGST1, LY96, CSF2RB, TNFRSF11A, KLRK1, STAP1, NLRP3, S100A14, ELANE, ABCA1, JUN, VCAM1, DEFA4, TNFRSF10C, TNFRSF10B, DEFA1, PPBP, SELE, NFKB1, CXCL10, CXCL11, IL6, ALPL, CXCL6, CXCL9, CD40, HMGB2, TNFAIP3, CXCL1, TREM2, FASLG, PTPN22, CXCL3, CXCL2, CXCL5, ALAD, THBD, DUSP10, PDE4B, CTSG, CCR7, CD36, CCR5, HAVCR2, PTGIR, CHUK, ARG1, IRAK3, PDCD1LG2, FOS, TNFRSF1B, DCN, IL1B, LTA, TLR4, CX3CR1, CEBPE, PTGER2, PTGS2, CNR1, CCL2, IL12RB2, GCH1, CCL20, NR1H2, LILRB1, LILRB2, MAPK14, CD6, LTBR, PF4]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[IL1RN, CSF3R, PROS1, SIRPG, CXCL13, F11R, CXCL16, VPREB3, EPS8, LGALS3, VPREB1, EDNRB, C3AR1, TNFSF11, IL6R, SLC16A3, CD177, CXADR, ATP1B2, MIF, ATP1B1, CH25H, PRTN3, S100A8, GYPA, CALCA, SDC2, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, GATA3, CORO1A, NUP85, INPP5D, IGLV1-44, S100A12, NCKAP1L, PLCG1, IGHA1, ELANE, NKX2-3, LYN, CCR1, TGFB2, TGFB1, GPR15, CAV1, FN1, TNFRSF10B, AZU1, DEFA1, PPBP, GP6, SELE, COL1A1, CXCL10, CXCL11, IL6, COL1A2, SELL, SDC1, IGKV3-20, IGHM, CXCL6, CXCL9, ITGAM, ITGB3, ITGB2, CXCL1, SLC7A11, CXCL3, ITGAL, CXCL2, TREM1, CXCL5, PDE4B, ITGAX, OLR1, FFAR2, CCR7, ITGB7, CCR6, CCR5, CD34, CCR2, ANXA1, FCER1G, SYK, ITGA4, MMP1, MMP9, VAV1, SLC7A5, ZAP70, HCK, CEACAM1, SLC7A7, SLC7A8, CEACAM6, LCK, IL1B, KIT, PECAM1, XCL1, CX3CR1, CCL13, CXCR5, CXCR4, CCL8, IGKC, CXCR1, CCL7, EPCAM, CCL5, CXCR2, CCL4, CCL2, CCL1, FYN, CD58, CCL19, CCL18, JAM2, JAM3, CCL23, CCL21, CCL20, CD2, NLRP12, PTPN6, TEK, CD244, PF4]
GO:0071345;cellular response to cytokine stimulus;5.0;0.6729672293956388;0.6267246265587396;8.214830917184116;61.59823360834823;3.805811787890007;0.0020616374440603005;0.48487040368196277;[PID1, TFRC, TCL1A, AKT1, TNFSF11, DAPK1, BTK, PADI2, STXBP2, GATA3, ADAMTS12, ST3GAL6, EGR1, COL1A1, CD40, BRCA1, CCR7, HLA-DPA1, MME, ARG1, SIRT1, TLR4, TLR2, CCL13, CXCR4, CD58, CCL19, CCL18, IL12RB1, CCL23, GSN, CCL21, CCL20, NLRP12, ZYX, IL18R1, IL17A, PYCARD, TLE4, PCOLCE, KMO, KIF16B, CSF1R, CALCA, CSF2RB, CORO1A, VCAM1, NFKB1, BSPRY, ALAD, CHUK, ITGA4, IL3RA, CHI3L1, XCL1, MCM2, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, MAPK14, KLF4, CD4, KLF5, IMPDH2, PTPN6, RBMX]
GO:0035924;cellular response to vascular endothelial growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;62.59148538135601;6.599019797332524;0.00209488068703431;0.6605944919115335;[NR4A1, NRP1, EGR3, ANXA1, VCAM1, AKT1, GAS1, MAPK14]
GO:0032930;positive regulation of superoxide anion generation;8.0;1.0;0.875;9.628524252492122;144.57516735605006;7.004484905440688;0.00483880074220378;0.7332096838060964;[TGFB1, ITGAM, PRKCD, ITGB2, FPR2, GNAI2, CD177]
